Edition:
United Kingdom

CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

25.95USD
21 Sep 2018
Change (% chg)

$0.09 (+0.35%)
Prev Close
$25.86
Open
$25.81
Day's High
$26.33
Day's Low
$25.59
Volume
975,614
Avg. Vol
229,828
52-wk High
$27.52
52-wk Low
$2.86

Chart for

About

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene... (more)

Overall

Beta: --
Market Cap(Mil.): $126.68
Shares Outstanding(Mil.): 22.54
Dividend: --
Yield (%): --

Financials

  CDNA.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.37 -- --
ROI: -68.64 1.79 14.61
ROE: -131.60 3.28 16.33

BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina

* CAREDX INC - ON MAY 4, 2018, CO ENTERED INTO A LICENSE AND COMMERCIALIZATION AGREEMENT WITH ILLUMINA, INC - SEC FILING

08 May 2018

BRIEF-Caredx Enters Into A Credit Agreement And Guaranty - SEC Filing

* CAREDX SAYS ON APRIL 17 ENTERED INTO A CREDIT AGREEMENT AND GUARANTY - SEC FILING

18 Apr 2018

BRIEF-Caredx Launches Heartcare For Heart Transplant Recipients

* ANNOUNCED LAUNCH OF HEARTCARE, A COMPREHENSIVE REJECTION SURVEILLANCE SOLUTION FOR HEART TRANSPLANT RECIPIENTS Source text for Eikon: Further company coverage:

10 Apr 2018

Competitors

Earnings vs. Estimates